aTyr Pharma
ATYR
52 hedge funds and large institutions have $23.1M invested in aTyr Pharma in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
21% more funds holding
Funds holding: 43 → 52 (+9)
3.24% more ownership
Funds ownership: 0% → 3.24% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
32% less capital invested
Capital invested by funds: $33.9M → $23.1M (-$10.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.86M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$122K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$93.7K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$58.5K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$53.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.64M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$917K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$440K |
| 4 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$347K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$314K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IA
51
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
MF
52
Magnetar Financial
Evanston,
Illinois
| – | -$440K | -9,890 | Closed |
|
|
JPC
53
Jackson Park Capital
Alpine,
Utah
| – | -$210K | -4,714 | Closed |
|
54
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$166K | -3,739 | Closed |
|
|
NFA
55
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$58.9K | -1,436 | -100% |
|
56
ProShare Advisors
Bethesda,
Maryland
| – | -$48K | -1,068 | Closed |
|
ATYR Hedge Fund Activity: Q4 2016 in Review
52 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q4 2016, worth a combined $23.1M — down 32% from $33.9M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ATYR positions and 4 closed out — a net gain of 10 holders — while 11 added to existing stakes and 15 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $2.86M. The largest seller was Federated Hermes, cutting an estimated $1.64M.
- 52 institutional investors held aTyr Pharma (ATYR) as of Q4 2016, up from 43 in Q3 2016.
- Funds reported $23.1M of aTyr Pharma stock for Q4 2016, down 32% quarter-over-quarter.
- 14 funds opened new aTyr Pharma positions in Q4 2016 and 4 closed out, a net change of +10 holders.
- The largest aTyr Pharma buyer in Q4 2016 was EcoR1 Capital, an estimated $2.86M added.
- The largest aTyr Pharma seller in Q4 2016 was Federated Hermes, an estimated $1.64M sold.
Based on aggregated 13F filings for Q4 2016.